Johnson & Johnson
JNJHealthcareGenerated Jul 4, 2026, 03:17 PM UTC
Hold on JNJ (Johnson & Johnson). Composite score -0 (confidence 80%). Net income up ▲ +95.9% YoY. Debt/equity 0.51, current ratio 1.03, net debt $19.75B. Market cap $633.19B at $263.04 per share. Trailing P/E 19.17, P/B 7.80. EV/Operating income ≈ 43.66 (EV $652.94B). Risk: Moderate. Macro: Risk-on · Supportive.
Free SEC analysis
— computed from SEC filings, free to readFundamentals
Net income up ▲ +95.9% YoY. Debt/equity 0.51, current ratio 1.03, net debt $19.75B.
- Net income up ▲ +95.9% YoY.
- Debt/equity 0.51, current ratio 1.03, net debt $19.75B.
| FY | Revenue | Rev YoY | Gross% | Op% | Net% | FCF | ROE% |
|---|---|---|---|---|---|---|---|
| 2016 | — | — | — | — | — | $15.00B | — |
| 2017 | — | — | — | — | — | $16.11B | — |
| 2018 | — | — | — | — | — | $15.54B | — |
| 2019 | — | — | — | — | — | $17.78B | — |
| 2020 | — | — | — | — | — | $18.53B | — |
| 2021 | — | — | — | — | — | $19.92B | — |
| 2022 | — | — | — | — | — | $20.19B | — |
| 2023 | — | — | — | — | — | $19.76B | — |
| 2024 | — | — | — | — | — | $17.18B | — |
| 2025 | — | — | — | — | — | $18.25B | — |
| Quarter end | Revenue | YoY | QoQ | Net margin |
|---|---|---|---|---|
| Sep 29, 2013 | $17.57B | — | — | 58.67% |
| Mar 30, 2014 | $18.11B | — | +3.1% | 26.09% |
| Jun 29, 2014 | $37.61B | — | +107.6% | 24.07% |
| Jun 29, 2014 | $19.50B | — | -48.2% | 46.44% |
| Sep 28, 2014 | $56.08B | — | +187.6% | 24.61% |
| Sep 28, 2014 | $18.47B | — | -67.1% | 74.74% |
Filings & Ownership
Latest annual report (10-K) filed Feb 11, 2026. Latest quarterly report (10-Q) filed Apr 22, 2026. 7 recent 8-K material-event filings in the index.
- Latest annual report (10-K) filed Feb 11, 2026.
- Latest quarterly report (10-Q) filed Apr 22, 2026.
- 7 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 0 sell transactions.
- ~10,000+ recent 13F-HR filings reference Johnson & Johnson; broad institutional reporting.
- Recent filers include LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA.
- 9 recent 13D activist/beneficial-ownership filings — potential catalyst.
- 11 recent 13G passive institutional ownership notices.
| Filer | Form | Filed |
|---|---|---|
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA | 13F-HR | May 15, 2003 |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA | 13F-HR | Aug 9, 2002 |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA | 13F-HR | May 8, 2001 |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA | 13F-HR | May 11, 2004 |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA | 13F-HR | Nov 2, 2001 |
| Date | Form | Description |
|---|---|---|
| Apr 28, 2026 | 8-K | 8-K |
| Apr 14, 2026 | 8-K | 8-K |
| Jan 21, 2026 | 8-K | 8-K |
| Oct 14, 2025 | 8-K | 8-K |
| Sep 9, 2025 | 8-K | 8-K |
| Jul 16, 2025 | 8-K | 8-K |
| Jun 10, 2025 | 8-K | 8-K |
Unlock the rest
- ProValuationMarket cap $633.19B at $263.04 per share.
- ProPrice & TechnicalsPrice $263.04 — uptrend (above 200-DMA); 1-month momentum positive.
- ProMacro & RatesMarket regime: Risk-on · Supportive.
- ProRisk ScorecardComposite risk: Moderate.
This content is for Pro subscribers
Unlock the full breakdown from all six analysts — fundamentals, valuation (DCF & Graham), technicals, macro, risk, and 13F/13D ownership — plus your personal advisor.
Demo mode: billing is simulated — you can activate Pro instantly from your account.
2 sections free · 4 Pro sections locked · composite -0
Macro exposure
Defensive · Low sensitivityMacro regime: Risk-on · Supportive. Johnson & Johnson is a defensive name (low macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.
Advisor read
deterministic previewPrice $263.04 — uptrend (above 200-DMA); 1-month momentum positive..
Peer comparison
Defensive groupHow JNJ stacks up against tracked peers with similar macro sensitivity — by rating, score and regime verdict.
| Company | Rating | Score | Macro |
|---|---|---|---|
| Johnson & Johnson JNJ● you | Hold | 0 | Neutral |
| Walmart Inc. WMT | Sell | -22 | Neutral |